Insider Trading & Ownership of Anne A. Finucane

Location
Woonsocket, RI
Summary
The estimated net worth of Anne A. Finucane is at least $2,977,920 dollars as of 03 Feb 2026. Anne A. Finucane is the Director of WILLIAMS SONOMA INC and owns shares of WILLIAMS SONOMA INC (WSM) stock worth about $1.68M. Anne A. Finucane is the Director of CVS HEALTH Corp and owns shares of CVS HEALTH Corp (CVS) stock worth about $1.3M.
Signature
/s/ David R. King, Attorney-in-Fact for Anne Finucane
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Anne A. Finucane and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Quick Takeaways

  • Anne A. Finucane has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $2,977,920.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: WILLIAMS SONOMA INC ($1,676,036).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Anne A. Finucane

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
WSM WILLIAMS SONOMA INC Director $1,676,036 02 Feb 2026
CVS CVS HEALTH Corp Director $1,301,884 -$532,650 -29% 20 Nov 2025

Insider Transactions Reported by Anne A. Finucane:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .